Tag: research
Eisai & Co and Bliss Biopharmaceutical (Hangzhou) Sign Agreement to Jointly...
Japanese drugmaker Eisai & Co and Chinese drug developer Bliss Biopharmaceutical (Hangzhou) Co., have entered into a joint development agreement to further develop BB-1701, an antibody-drug conjugate (ADC). As part of the agreement Eisai & Co obtained option rights for a strategic collaboration.
SOTIO and LegoChem Biosciences Sign Exclusive Collaboration and License Agreement
Clinical stage immuno-oncology company SOTIO Biotech and LegoChem Biosciences (LCB), a biotechnology company focused on developing its clinical-stage platform technology to develop antibody-drug conjugates...
Eric Rosenthal Reports | A Personal Remembrance of Two Giants of...
James F. Holland, MD, one of the pioneers of combination chemotherapy and cancer cooperative group research, died at the age of 92 on March...
A Call to Action: Submit Your Expertise
Valuable lessons learned from both approved antibody-drug conjugates (brentuximab vedotin /Adcetris®; Seattle Genetics approved in 2011 and ado-trastuzumab emtansine or T-DM-1/Kadcyla® approved in 2013)...
Death of the Great Laboratory of Clinical Medical Science
Free-market capitalism has brought unimaginable innovations to mankind in the last 200 years, more so than any other economic system in the history of...
